Advanced search
Publication Cover
Journal of Investigative Surgery Volume 23, 2010 - Issue 6
Submit an article Journal homepage
54
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Characterization and Signaling in a Primary Human Malignant Fibrous Histiocytoma Cell Line

Shouye WangDepartment of Surgery, Michigan State University, Lansing, Michigan, USA
, PhD,
Shahzad BulsaraDepartment of Surgery, Michigan State University, Lansing, Michigan, USA
, MD &
Marc D. BassonDepartment of Surgery, Michigan State University, Lansing, Michigan, USACorrespondence[email protected]
, MD, PhD
Pages 303-308 | Received 07 Jul 2010, Accepted 27 Jul 2010, Published online: 05 Jan 2011

REFERENCES

  • Nakayama R, Nemoto T, Takahashi H, Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol. 2007;20(7):749–759.
  • Mahalingam D, Mita A, Sankhala K, Targeting sarcomas: novel biological agents and future perspectives. Curr Drug Targets. 2009;10(10):937–949.
  • O'Brien JE, Stout AP. Malignant Fibrous Xanthomas. Cancer. 1964;17:1445–1455.
  • Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol. 2008;97(4):330–339.
  • Belal A, Kandil A, Allam A, Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol. 2002;25(1):16–22.
  • Cheng GZ, Park S, Shu S, Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets. 2008;8(1):2–6.
  • Carnero A. The PKB/AKT pathway in cancer. Curr Pharm Des. 2010;16(1):34–44.
  • Sheng S, Qiao M, Pardee AB. Metastasis and AKT activation. J Cell Physiol. 2009;218(3):451–454.
  • Hernando E, Charytonowicz E, Dudas ME, The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med. 2007;13(6):748–753.
  • Tomita Y, Morooka T, Hoshida Y, Prognostic significance of activated AKT expression in soft-tissue sarcoma. Clin Cancer Res. 2006;12(10):3070–3077.
  • Zhu QS, Ren W, Korchin B, Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha. Cancer Res. 2008;68(8):2895–2903.
  • Delhase M, Li N, Karin M. Signalling pathways: kinase regulation in inflammatory response. Nature. 2000; 406(6794):367–368.
  • Sugii S, Olson P, Sears DD, PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci. 2009;106(52):22504–22509.
  • Gang S, Gaoliang O, Yubin M, Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1 up-regulation and MMP9 activation. J Cell Mol Med. 2009;13(8b):1706–1718.
  • Hennenlotter J, Merseburger AS, Ohneseit PA, Pten-independent activation of the PKB/AKT pathway in renal cell cancer and inactivation of p27KIP by phosphorylation at T157. Eur Urol Suppl. 2006;5(2):28–28.
  • Liu Z, Zhang HM, Yuan J, Focal adhesion kinase mediates the IGTP-induced PI3K/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation. Cell Microbiol. 2008;10(9):1787–1800.
  • Reif S, Lang A, Lindquist JN, The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem. 2003;278(10):8083–8090.
  • Sonoda Y, Watanabe S, Matsumoto Y, FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem. 1999;274(15):10566–10570.
  • Konstantinopoulos PA, Fountzilas E, Goldsmith JD, Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance. PLoS One. 2010;5(4):e9747.
  • Gills J, Dennis P. Perifosine: update on a novel Akt inhibitor. Curr Oncol Rep. 2009;11(2):102–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.